Filing Flows

Filing Flows › Merck (MRK) › Next earnings date

Merck (MRK) earnings: beat the estimate

Merck (MRK) reported on Oct 29, 2026 and beat the EPS estimate: $2.49 against $2.08 (+19.6%). Revenue was $18.1B for Q3 2026, +5% year over year. The stock moved +6.1% on the report. It beat the EPS estimate in 100% of the quarters on record.

Last result+19.6% vs estimate
Beat rate100%

The last report

Merck reported revenue of $18.1B for the third quarter 2026 (+5% Y/Y), net earnings $5.1B. How it makes money → · Every quarter →

Merck: EPS against the estimate, last 5 reportsMerck: EPS against the estimate, last 5 reportsEstimateReported$2.35$2.58Oct 25$2.01$2.04Feb 26−$1.47−$1.28Apr 26−$0.26−$0.13Aug 26$2.08$2.49Oct 26
Latest (Oct 26): Estimate $2.08, Reported $2.49.
MRK: the stock's move on each reportMRK: the stock's move on each reportOct 29, 2026+6.1%Aug 4, 2026+0.4%Apr 30, 2026+1.1%Feb 3, 2026+4.4%Oct 30, 2025-0.7%

Merck's latest quarter

Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.

Questions

Did Merck beat earnings?

Merck (MRK) reported on Oct 29, 2026 and beat the EPS estimate: $2.49 against $2.08 (+19.6%).

When does MRK report earnings?

The next date is not set yet.

Does Merck usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.